Featured Posters & Presentations
Lyfgenia
Predictors of biologic efficacy with lovotibeglogene autotemcel (lovo-cel) gene therapy in patients with sickle cell disease.
Authors: Kinney MA.
Zynteglo
Mobilization and apheresis experience in patients receiving one-time beti-cel gene therapy for transfusion-dependent β-thalassemia: a pooled analysis.
Authors: Schneiderman J.
Zynteglo
Sustained efficacy and safety in adult and pediatric patients with transfusion-dependent β-thalassemia up to 9 years post treatment with betibeglogene autotemcel (beti-cel).
Authors: Walters MC.